Inhaled lysine acetylsalicylate (L-ASA) attenuates histamine-induced bronchoconstriction in asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 3, 1996, Pages 157-163

  Crimi, N ^a   Polosa, R ^a   Magri S ^a   Prosperini, G ^a   Paolino, G ^a   Mastruzzo, C ^a   Mistretta, A ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Asthma; Bronchacanstriction; Histamine; Lysine acetylsalicylate

Indexed keywords

HISTAMINE; LYSINE ACETYLSALICYLATE;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0029899912     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04580.x     Document Type: Article

References (29)

1. Black JW, Duncan WAM, Durant CJ, Ganellin R, Parsons EM. Definitions and antagonism of histamine H-2 receptors. Nature 1972;236:385-90.
2. Rosa LM, McDowall RJS. The action of the local hormones on the isolated human bronchus. Acta Allergol 1951; 4:293-304.
3. Itkin IH. Bronchial hypersensitivity to methacholine and histamine in asthma subjects. J Allergy 1967;40:245-56.
4. Cartier A, Malo J-L, Begin B, Sestier M, Martin RR. Time course of the bronchoconstriction induced by inhaled histamine and methacholine. J Appl Physiol 1983;54:821-6.
5. Casterline CL, Evans R. Further studies on the mechanism of human histamine-induced asthma. J Allergy Clin Immunol 1977;59:420-4.
6. Leopold JD, Hartley JRR, Smith AP. Effects of oral H1 and H2-receptor antagonists in asthma. Br J Clin Pharmacol 1979;8:249-51.
7. 1-receptor antagonist in asthmatic airways. Am Rev Respir Dis 1987;135:181-4.
8. 1-antihistamine drug-treatments of asthma. J Allergy Clin Immunol 1985;76:375-82.
9. 1 histamine receptor antagonist terfenadine alone and in combination on allergen-induced immediate bronchoconstriction in man. Thorax 1987;42:946-52.
10. Fish JE, Ankin MG, Adkinson NF, Peterman VI. Indomethacin modification of the immediate-type immunologic airway responses in allergic asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1981;123:609-14.
11. Phillips GD, Holgate ST. The effect of oral terfenadine alone and in combination with flurbiprofen on the broncho-constrictor response to inhaled adenosine 5′-monophos-phate in non-atopic asthma. Am Rev Respir Dis 1989;139: 463-9.
12. Polosa R, Lai CKW, Robinson C, Holgate ST. The influence of cyclooxygenase inhibition on the loss of broncho-constrictor response to repeated bradykinin challenge in asthma. Eur Respir J 1990;3:914-21.
13. Walters EH. Prostaglandins and the control of airways responses to histamine in normal and asthmatic subjects. Thorax 1983;38:188-94.
14. Bianco S, Vaghi A, Pieroni MG, Robuschi M, Refini RM, Berni F, Sestini P. Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate. Allergy 1993;48:570-5.
15. Bianco S, Vaghi A, Pieroni MG, Robuschi M, Refini RM, Sestini P. Protective activity of inhaled nonsteroidal antiinflammatory drugs on bronchial responsiveness to ultrasonically nebulized water. J Allergy Clin Immunol 1992;90:833-9.
16. Crimi N, Polosa R, Magri S, et al. Inhaled L-ASA attenuates the bronchoconstrictor response to AMP in asthmatic subjects. Eur Respir J 1995;8:905-12.
17. Crimi N, Polosa R, Prosperini G, Magri S, Mistretta A. Attenuation of the airways responsiveness to NKA by inhaled L-ASA in asthmatic subjects. Am J Respir Crit Care Med 1994;149 Suppl 2:A891.
18. American Thoracic Society. Statements on standards for diagnosis and care of patients with chronic obstructive pulmonary disease and asthma. Am Rev Respir Dis 1987; 136:225-44.
19. Lewis RA. Therapeutic aerosols. In: Cumming G, Bonsignore C, editors. Drugs and the lung. London: Plenum, 1984:63-86.
20. Chai H, Farr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7.
21. Crook D, Collins AJ, Rose AJ. A comparison of the effect of flurbiprofen on prostaglandin synthetase from human rheumatoid synovium and enzymatically active animal tissues [Abstract]. J Pharm Pharmacol 1976;28:535.
22. Sterk PJ, Daniel EE, Zamel N, Hargreave FE. Limited maximal airway narrowing in nonasthmatic subjects. Role of neural control and prostaglandin release. Am Rev Respir Dis 1985;132:865-70.
23. Platshon LF, Kaliner M. The effect of the immunologic release of histamine on human lung cyclic nucleotide levels and prostaglandin generation. J Clin Invest 1978;63:1113-21.
24. Adkinson NF, Newball HH, Findlay S, Adams K, Lichtenstein LM. Anaphylactic release of prostaglandins from human lung in vitro. Am Rev Respir Dis 1980;121:911-20.
25. 2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis 1986; 133:252-4.
26. Walters EH, Parrish RW, Bevan C, Smith AP. Induction of bronchial hypersensitivity: evidence for a role for prostaglandins. Thorax 1981;36:571-4.
27. Campbell AM, Robinson C. Further studies on IgE-mediated eicosanoid release from human dispersed lung cells. Br J Pharmacol 1988;95 Suppl:674 pp.
28. Peters SP, MacGlashan DW, Schleimer RP, Hayes EC, Adkinson NE, Lichtenstein LM. The pharmacological modulation of the release of arachidonic acid metabolites from purified human lung mast cells. Am Rev Respir Dis 1985;135:367-73.
29. Fine JM, Gordon T, Thompson JE, Sheppard D. The role of titratable acidity in acid aerosol-induced bronchoconstriction. Am Rev Respir Dis 1987;135:826-30.